Aerobic Exercise for Cancer Survivors
Trial Summary
What is the purpose of this trial?
This is a pilot feasibility study of an investigation of the influence of excess adiposity on cardiorespiratory fitness (CRF), insulin-like growth factor-1 (IGF-1), and metabolic responses to a standardized aerobic exercise program in cancer survivors. This investigation attempts to isolate the influence of adiposity on these responses. We will enroll overweight, obese, and normal weight cancer survivors with a primary diagnosis of breast, prostate, or colorectal cancer who have completed all cancer-related treatment. Participants will engage in a 15-week aerobic exercise intervention with pre- and post-intervention assessments.
Research Team
Ryan Marker, PT, PhD
Principal Investigator
University of Colorado, Denver
Eligibility Criteria
This trial is for breast, prostate, or colorectal cancer survivors who are overweight or obese. They should have finished their cancer treatments between 6 months and 5 years ago and must be able to do supervised exercise with a doctor's clearance.Inclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants engage in a 15-week standardized aerobic exercise intervention
Follow-up
Participants are monitored for adherence and physiological responses post-intervention
Treatment Details
Interventions
- Aerobic Exercise
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Colorado, Denver
Lead Sponsor